Quest Diagnostics DGX · NYSE
$241.81 -0.60% (-$1.47)
Summary
59 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 14 years in a row and pays out only 35% of profit.
- Out of every 100 USD of revenue, 11 USD is left as free cash.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 24.4 USD for 1 USD of yearly profit. Over the last five years it was 17.6 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 3.2% a year over 5 years. Over the last 3 years it grew by 3.7% a year. For the next fiscal year analysts expect revenue to grow by 9.3%. Earnings per share grew by 3.1% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 67 USD
- Sales and administration 19 USD
- Taxes and other 5.1 USD
- Net profit 9.5 USD
Net profit, industry median (Medical - Diagnostics & Research) 8.8 USD
Out of every 100 USD of revenue, 9.5 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.6 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.44%
- Paid out of profit
- 35%
- Raised in a row
- 14 years
You receive $3.38 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 13
- Hold 18
- Sell 3
Today's price within the analysts' price targets
The average target of $248.57 is 2.8% above today's price. 38% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Diagnostic Information Services Business 100%
By region
The company reports no revenue by region.
Diagnostic Information Services Business brings in 100% of revenue.
Segments in detail